YU22703A - Postupak za izolovanje farmaceutski primenljivog dinatrijumetidronata - Google Patents

Postupak za izolovanje farmaceutski primenljivog dinatrijumetidronata

Info

Publication number
YU22703A
YU22703A YU22703A YUP22703A YU22703A YU 22703 A YU22703 A YU 22703A YU 22703 A YU22703 A YU 22703A YU P22703 A YUP22703 A YU P22703A YU 22703 A YU22703 A YU 22703A
Authority
YU
Yugoslavia
Prior art keywords
etidronate disodium
liquid
exploitable
isolating
pharmaceutically
Prior art date
Application number
YU22703A
Other languages
English (en)
Inventor
Detlef Grawe
Barbara Schmidt
Harald Rathe
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of YU22703A publication Critical patent/YU22703A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/386Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pronalazak se odnosi na postupak za izolovanje dinatrijumetidronata, pri čemu se a) tečnost-tečnost disperzija sastavljena iz - jedne vodeno-organske i - jedne vodene faze koja sadrži dinatrijumetidronat postavi na temperaturu od 0В°C do 30В°C i intenzivno meša, b) zatim se iz tečno-tečno disperzije istaloži krupnozrna frakcija, c) u drugom produženom koraku iz organske faze istaloži frakcija finog zrna, kao i novi oblik čvrstog tela ninatrijumetidronata, koji može da se dobije ovim postupkom. Pripremljen je postupak za dobijanje dinatrijumetidronata sa veličinom zrna u području od 0,2 do 1,0 mm, sa dobrom sposobnošću sipanja, odnosno visokom nasipnom gustinom i sa tim vezano visokom farmaceutskom primenljivošću.[The invention relates to a method for isolating etidronate disodium. According to said method, a liquid-liquid dispersion consisting of an aqueous-organic phase and an aqueous phase containing the etidronate disodium salt is set to a temperature of between 0 В°C and 30 В°C and is intensively mixed; a coarse-grained fraction is subsequently precipitated out of the liquid-liquid dispersion and in a second, delayed step, a fine-grained fraction is precipitated out of the organic phase. The invention also relates to a novel solid form of etidronate disodium that can be obtained using this method. The invention provides a method for producing etidronate disodium with a particle size in the region of 0.2 to 1.0 mm, good flowability and a high bulk density, coupled with properties that can be pharmaceutically exploited to advantage.
YU22703A 2000-09-28 2001-09-28 Postupak za izolovanje farmaceutski primenljivog dinatrijumetidronata YU22703A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10049735A DE10049735A1 (de) 2000-09-28 2000-09-28 Verfahren zur Isolierung von pharmazeutisch verwertbarem Etidronat-Dinatrium

Publications (1)

Publication Number Publication Date
YU22703A true YU22703A (sh) 2006-08-17

Family

ID=7659017

Family Applications (1)

Application Number Title Priority Date Filing Date
YU22703A YU22703A (sh) 2000-09-28 2001-09-28 Postupak za izolovanje farmaceutski primenljivog dinatrijumetidronata

Country Status (30)

Country Link
US (1) US6974885B2 (sh)
EP (1) EP1320535B1 (sh)
JP (1) JP3759927B2 (sh)
KR (1) KR100562822B1 (sh)
CN (1) CN1244586C (sh)
AT (1) ATE273314T1 (sh)
AU (2) AU2344902A (sh)
BG (1) BG107668A (sh)
BR (1) BR0114281A (sh)
CA (1) CA2434790C (sh)
CZ (1) CZ2003880A3 (sh)
DE (2) DE10049735A1 (sh)
DK (1) DK1320535T3 (sh)
EA (1) EA004688B1 (sh)
EE (1) EE200300122A (sh)
ES (1) ES2227308T3 (sh)
HK (1) HK1061859A1 (sh)
HR (1) HRP20030335B1 (sh)
HU (1) HUP0301226A3 (sh)
IL (2) IL155081A0 (sh)
MX (1) MXPA03002666A (sh)
NO (1) NO20031399L (sh)
NZ (1) NZ525142A (sh)
PL (1) PL361060A1 (sh)
PT (1) PT1320535E (sh)
SK (1) SK3912003A3 (sh)
UA (1) UA73612C2 (sh)
WO (1) WO2002026751A1 (sh)
YU (1) YU22703A (sh)
ZA (1) ZA200303212B (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2940105C (en) * 2014-02-27 2022-07-05 Unilever Plc Water soluble laundry capsule comprising reduced levels of fines in hedp

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL124638C (sh) * 1961-07-03
US3855284A (en) * 1963-11-02 1974-12-17 Henkel & Cie Gmbh Process for the manufacture of phosphonic acids and phosphonates having at least two phosphorus atoms
DE1261850B (de) * 1965-03-30 1968-02-29 Procter & Gamble Verfahren zur Herstellung von AEthan-1-hydroxy-1,1-diphosphonsaeure
NL149701C (nl) * 1965-12-08 1981-05-15 Procter & Gamble Werkwijze voor het bereiden van een tegen tandsteen werkzaam tandverzorgingsmiddel, dat als werkzaam bestanddeel een fosfonzuurderivaat bevat, alsmede gevormd tandverzorgingsmiddel.
US3497313A (en) * 1966-12-29 1970-02-24 Procter & Gamble Carbonyldiphosphonates
US3527795A (en) * 1967-11-20 1970-09-08 Monsanto Co Process for preparing water-soluble salts of organic phosphorus acids
NL175882C (nl) * 1977-03-28 Procter & Gamble Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
GB2095694B (en) * 1981-03-31 1984-08-01 Hollaway E R Ltd Tooth cleaning compositions
US4504463A (en) * 1982-06-10 1985-03-12 Mallinckrodt, Inc. Process for making a lyophilized product for use in skeletal imaging
US6143923A (en) * 1996-10-02 2000-11-07 Lonza Inc. Process for manufacturing 1-hydroxyalkylidene-1,1-diphosphonic acid (HADP)

Also Published As

Publication number Publication date
DE10049735A1 (de) 2002-04-18
CN1244586C (zh) 2006-03-08
BG107668A (bg) 2003-09-30
CN1466589A (zh) 2004-01-07
HUP0301226A3 (en) 2005-02-28
HK1061859A1 (en) 2004-10-08
PT1320535E (pt) 2004-12-31
DK1320535T3 (da) 2004-12-20
EA200300396A1 (ru) 2003-10-30
EE200300122A (et) 2005-04-15
HRP20030335A2 (en) 2005-04-30
BR0114281A (pt) 2003-07-29
UA73612C2 (en) 2005-08-15
EP1320535A1 (de) 2003-06-25
CA2434790A1 (en) 2002-04-04
WO2002026751A1 (de) 2002-04-04
CZ2003880A3 (cs) 2003-12-17
PL361060A1 (en) 2004-09-20
ZA200303212B (en) 2004-02-26
EA004688B1 (ru) 2004-06-24
ATE273314T1 (de) 2004-08-15
NZ525142A (en) 2004-11-26
IL155081A (en) 2006-12-31
NO20031399D0 (no) 2003-03-27
AU2002223449B2 (en) 2007-03-22
AU2344902A (en) 2002-04-08
NO20031399L (no) 2003-05-27
ES2227308T3 (es) 2005-04-01
JP3759927B2 (ja) 2006-03-29
SK3912003A3 (en) 2003-09-11
US20040024245A1 (en) 2004-02-05
CA2434790C (en) 2008-05-13
JP2004509969A (ja) 2004-04-02
EP1320535B1 (de) 2004-08-11
KR20030077532A (ko) 2003-10-01
DE50103250D1 (de) 2004-09-16
HUP0301226A2 (hu) 2003-09-29
US6974885B2 (en) 2005-12-13
IL155081A0 (en) 2003-10-31
KR100562822B1 (ko) 2006-03-23
HRP20030335B1 (en) 2006-04-30
MXPA03002666A (es) 2004-09-10

Similar Documents

Publication Publication Date Title
AUPP355798A0 (en) Process for the production of ultrafine powders
MXPA03007053A (es) Suspension de cemento de muy baja densidad.
WO2002013786A3 (en) Method of forming microparticles
SE0000454D0 (sv) Iron powder and method for the preparaton thereof
AU2002223558A1 (en) Method for producing polymer coated pigment particles by precipitation
AU2002365069A1 (en) High quality colloidal nanocrystals and methods of preparation of the same in non-coordinating solvents
PL346244A1 (en) Method for producing aqueous dispersions of (co)polymers, dispersions obtained using said method, redispersible powders which can be obtained from said dispersions and use thereof
BR0206164A (pt) Partìculas cristalinas de oxalato de escitalopram, método para a produção de partìculas cristalinas de oxalato de escitalopram, e, forma de dosagem unitária sólida
CA2430318A1 (en) Powder formulation and method for producing the same
CA2138125A1 (en) Process for Making Compact Detergent Compositions
MY121489A (en) Process for producing rare earth metal-based permanent magnet having corrosion-resistant film
WO2003031466A3 (en) Angiotensin peptide-carrier conjugates and uses thereof
EP1859787A3 (de) Aufstreuverfahren zur Herstellung von Pulverformulierungen
AU2680000A (en) Cementitious compositions
HK1037622A1 (en) Particle-forming compositions containing fused pyrrolocarbrazoles
YU22703A (sh) Postupak za izolovanje farmaceutski primenljivog dinatrijumetidronata
NO924938L (no) Fremgangsmaate for fremstilling av kobberpulver
DK1135108T3 (da) Fremgangsmåde til fremstilling af agglomerater med kerne-skal struktur
AU2002321293A1 (en) Process for the preparation of methionine
MY139687A (en) Ceramics particle
MY128492A (en) Blowing agent powder and process for producing the same
DE60102485D1 (de) Herstellung von aluminium-silizium-legierungen
TW200517504A (en) Producing method of sintered ore, producing method of material for sintered ore, agglomerated particle and sintered ore
MY135453A (en) Recycled ceramic slurry, recycled ceramic powder, ceramic electronic part, and fabricating methods therefor
EP1118404A4 (en) ALLOY POWDER, SINTERED ALLOY PELLETS AND METHOD FOR THE PRODUCTION THEREOF